Register for email alerts and news feeds:
This journal | BMJ Group
rss
Tobacco Control 2004;13:422-428; doi:10.1136/tc.2003.007070
Copyright © 2004 by the BMJ Publishing Group Ltd.
Tobacco Control 2004;13:422-428
© 2004 BMJ Publishing Group Ltd

RESEARCH PAPER

Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers

J O’Loughlin1,*, G Paradis1,*, W Kim4, J DiFranza3, G Meshefedjian2, E McMillan-Davey2, S Wong4, J Hanley1 and R F Tyndale4

1 Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, Québec, Canada
2 Direction de santé publique de Montréal-Centre, Montréal, Québec, Canada
3 Department of Family Medicine and Community Health, University of Massachusetts Medical School, Worcester, Massachusetts, USA
4 Centre for Addictions and Mental Health, Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada

Correspondence to:
Correspondence to:
Dr Jennifer O’Loughlin
Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, 1020 Pine Avenue West, Montréal, Québec, Canada H3A 1A3; jennifer.oloughlin{at}mcgill.ca

Objective: Case control studies in adults suggest that defective alleles in the gene that codes for the hepatic cytochrome P450 2A6 (CYP2A6) protect against nicotine dependence (ND) and higher levels of cigarette consumption. These two hypotheses were tested in young adolescents.

Design: Self reports of tobacco use and ND symptoms were collected every 3–4 months in a prospective study of 1293 grade 7 students from a convenience sample of 10 schools.

Subjects: 281 smokers with genetic data were analysed; those who were not already tobacco dependent and who had inhaled (n = 228) were followed 29.9 months on average, until they became dependent or were censored.

Main outcome measures: The association between metabolic activity, represented by CYP2A6 genotype, and conversion to dependence was analysed using Cox’s proportional hazards model.

Results: During follow up 67 subjects (29.4%) became dependent. Relative to CYP2A6*1/*1, having 1–2 copies of the inactive CYP2A6*2 or *4 variant was a strong risk factor for developing dependence (hazard ratio 2.8, 95% confidence 1.3 to 6.3). Subjects with 1–2 partially inactive CYP2A6*9 or *12 variants were not at increased risk. Mean past-week cigarette consumption at the end of follow up (controlling for age, sex, and number of months since first inhalation) among dependent subjects was 29.1 among normal inactivators, compared to 17.2, and 12.7 among slower (1–2 copies of *9 or *12), and slowest (1–2 copies of *2 or *4) inactivators, respectively (p = 0.09).

Conclusion: Adolescents with 1–2 copies of CYP2A6*2 or *4 are at substantially increased risk of becoming dependent but smoke less once dependent. Genetic risk for ND may need to be considered in the conceptualisation of tobacco control programmes for adolescents.

Keywords: CYP2A6; adolescent; nicotine dependence; smoking onset; tobacco use


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Rende, R., Slomkowski, C. (2009). Incorporating the Family as a Critical Context in Genetic Studies of Children: Implications for Understanding Pathways to Risky Behavior and Substance Use. J Pediatr Psychol 34: 606-616 [Abstract] [Full Text]  
  • Moolchan, E. T., Parzynski, C. S., Jaszyna-Gasior, M., Collins, C. C., Leff, M. K., Zimmerman, D. L. (2009). A Link between Adolescent Nicotine Metabolism and Smoking Topography. Cancer Epidemiol. Biomarkers Prev. 18: 1578-1583 [Abstract] [Full Text]  
  • Rubinstein, M. L., Benowitz, N. L., Auerback, G. M., Moscicki, A.-B. (2008). Rate of Nicotine Metabolism and Withdrawal Symptoms in Adolescent Light Smokers. Pediatrics 122: e643-e647 [Abstract] [Full Text]  
  • Ho, M. K., Tyndale, R. F. (2008). Role of CYP2A6 Genetic Variation on Smoking Behaviors and Clinical Implications. Am Soc Clin Oncol Ed Book 2008: 74-78 [Abstract] [Full Text]  
  • Kandel, D. B., Hu, M.-C., Schaffran, C., Udry, J. R., Benowitz, N. L. (2007). Urine Nicotine Metabolites and Smoking Behavior in a Multiracial/Multiethnic National Sample of Young Adults. Am J Epidemiol 165: 901-910 [Abstract] [Full Text]  
  • Audrain-McGovern, J., Koudsi, N. A., Rodriguez, D., Wileyto, E. P., Shields, P. G., Tyndale, R. F. (2007). The Role of CYP2A6 in the Emergence of Nicotine Dependence in Adolescents. Pediatrics 119: e264-e274 [Abstract] [Full Text]  
  • Malaiyandi, V., Goodz, S. D., Sellers, E. M., Tyndale, R. F. (2006). CYP2A6 Genotype, Phenotype, and the Use of Nicotine Metabolites as Biomarkers during Ad libitum Smoking.. Cancer Epidemiol. Biomarkers Prev. 15: 1812-1819 [Abstract] [Full Text]  
  • Karp, I, O'Loughlin, J, Hanley, J, Tyndale, R F, Paradis, G (2006). Risk factors for tobacco dependence in adolescent smokers. Tobacco Control 15: 199-204 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.